Suppr超能文献

对于在肺部 SBRT 期间每日图像引导中观察到的大肿瘤位置位移的患者,是否需要适应性计划?

Is adaptive planning necessary for patients with large tumor position displacements observed on daily image guidance during lung SBRT?

机构信息

Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA; Department of Radiation Oncology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298.

Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA.

出版信息

Med Dosim. 2022;47(3):207-215. doi: 10.1016/j.meddos.2022.02.008. Epub 2022 Apr 2.

Abstract

For patients undergoing stereotactic body radiation therapy for lung cancer, their tumor positions may vary due to anatomical changes. This study is to investigate whether adaptive re-planning is necessary for patients with large tumor position displacements observed from daily kV-cone-beam computed tomography (kV-CBCT). We selected 16 fractions from 16 patients with recorded treatment couch shifts greater than 1.5 cm under kV-CBCT guidance. The treatment positions for these patients were manually restored in kV-CBCTs via bone-to-bone alignments (B2B) and tumor-to-tumor alignments (T2T) with corresponding planning CTs. The tumor volumes, including PTVs, ITVs, and GTVs, were transferred from the planning CTs to these kV-CBCTs. With the planned beam configurations and treatment isocenters, kV-CBCTs were imported into the treatment planning system for dose recalculations. To minimize uncertainties of the Hounsfield Unit (HU) in kV-CBCTs, uniformed HU values were assigned to the externals, ITVs, and lungs. The percentage volumes of GTVs, ITVs, and PTVs receiving the prescription dose (V) and the dose to the normal structures were analyzed. Seven out of the 16 patients were identified with >5mm tumor position displacements after subtracting the recorded couch shifts from the shifts of B2B alignment. For T2T alignments, 9 out of 16 (56.3%) patients had V of PTV <95% (the planning goal) with 91.4% as the lowest, while V of the GTV and ITV remained 100% for all 16 patients. For B2B alignments, 14 out of 16 (87.5%) patients have V of PTV <95%; 5 patients (31.3%) had V of ITV <95%; and 4 patients (25.0%) had V of GTV <99%. T2T alignment with 5 mm PTV margin was found superior to B2B alignment, resulting in adequate dose coverage to the ITVs, even for tumors with large positional changes. Adaptive re-planning may not be necessary under these scenarios.

摘要

对于接受立体定向体部放射治疗(SBRT)的肺癌患者,由于解剖结构的变化,其肿瘤位置可能会发生变化。本研究旨在探讨对于在千伏锥形束 CT(kV-CBCT)引导下观察到的肿瘤位置明显位移大于 1.5cm 的患者,是否需要进行自适应再计划。我们选择了 16 名患者,这些患者在 kV-CBCT 引导下治疗床位移大于 1.5cm,在记录中存在治疗位置变化。通过骨对骨(B2B)和肿瘤对肿瘤(T2T)的配准,将这些患者的治疗位置手动恢复到 kV-CBCT 中,并与相应的计划 CT 进行配准。将肿瘤体积(包括 PTV、ITV 和 GTV)从计划 CT 转移到这些 kV-CBCT 中。使用计划的射束配置和治疗等中心点,将 kV-CBCT 导入治疗计划系统进行剂量重新计算。为了最小化 kV-CBCT 中亨氏单位(HU)的不确定性,将统一的 HU 值分配给外部、ITV 和肺。分析了 GTV、ITV 和 PTV 接收处方剂量(V)的体积百分比和正常结构的剂量。在从记录的治疗床位移中减去 B2B 配准的位移后,有 7 名患者的肿瘤位置位移大于 5mm。对于 T2T 配准,16 名患者中有 9 名(56.3%)的 PTV 的 V 小于 95%(计划目标),最低为 91.4%,而所有 16 名患者的 GTV 和 ITV 的 V 均为 100%。对于 B2B 配准,16 名患者中有 14 名(87.5%)的 PTV 的 V 小于 95%;5 名患者(31.3%)的 ITV 的 V 小于 95%;4 名患者(25.0%)的 GTV 的 V 小于 99%。我们发现,对于肿瘤位置变化较大的患者,使用 5mm 的 PTV 边界的 T2T 配准优于 B2B 配准,能够充分覆盖 ITV 的剂量。在这些情况下,可能不需要进行自适应再计划。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验